FRANKLIN LAKES, N.J., April 26, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony™ S6 cell sorter, which will be on display at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new platform... Read more
FRANKLIN LAKES, N.J., April 19, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced several new informatics and automation solutions for clinical laboratories, which may play a critical role in the fight against infectious diseases and antimicrobial resistance. The new molecular, microbiology and software solutions will be showcased... Read more
FRANKLIN LAKES, N.J., March 22, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it is updating the instructions for use of certain BD Vacutainer® tubes as part of its quality process to ensure that customers understand the appropriate uses of these products. Since BD became... Read more
FRANKLIN LAKES, N.J., March 19, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has signed a definitive agreement to divest its remaining, minority stake in Vyaire Medical to funds managed by Apax Partners. According to the terms of the agreement, BD will receive $435... Read more
19 March 2018 Chicago and London, March 19, 2018 – Funds advised by Apax Partners (“the Apax Funds”) today announced they have entered into a definitive agreement to purchase from BD (Becton, Dickinson and Company) its remaining ownership interest in Vyaire Medical, Inc., a global leader in respiratory care. Upon completion of the transaction, which... Read more
FRANKLIN LAKES, N.J., March 8, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Barclays Global Healthcare Conference on Wednesday, March 14, 2018, at 1:35 p.m. ET. A live webcast of BD’s presentations can be accessed from the BD corporate website... Read more
LAS VEGAS, March 5, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate its comprehensive approach to integrated, enterprise medication management to help close the communication gaps across the medication management process through increased interoperability, enhanced cybersecurity and expanded partnerships at the 2018 HIMSS Annual Conference being... Read more
FRANKLIN LAKES, N.J., March 1, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX) announced today the results of its previously announced offer to repurchase (the “Offer”) any and all of its outstanding 3.000% Notes due May 15, 2026 (the “Notes”) in accordance with the terms and conditions set forth in the offer to repurchase,... Read more
FRANKLIN LAKES, N.J., Feb. 28, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Raymond James 39th Annual Institutional Investors Conference on Tuesday, March 6, 2018, at 2:15 p.m. EST. Live webcasts of BD’s presentations can be accessed from the BD... Read more
LOS ANGELES, Feb. 1, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new LA County program to help ensure proper containment and disposal of household sharps, a health concern that when disposed of improperly could cause injury or spread infection according to the U.S. Food... Read more